FREDERIC H MOLL
CIK 1260157 · Executive Chairman · last filed 2026-06-10
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$58.52M
Companies
7
Total Filings
94
Lifetime Open-Market Net
-$4.74M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| PRCT | Director | 866,474 | $17.79 | $15.41M | $7.72M | 9 | 2026-06-10 |
| SSII | Director | 10,775,485 | $4.00 | $43.10M | $2.00M | 1 | 2026-03-10 |
| Shockwave Medical, Inc. (SWAV) Delisted | Director | 33,960 | $334.75 | $11.37M | -$15.92M | 11 | 2024-05-31 |
| Intersect ENT, Inc. (XENT) Delisted | Director | 260,961 | $28.24 | $7.37M | -$947.9K | 23 | 2021-02-05 |
| Venus Concept Inc. (HAIR) Delisted | Director | 13,825 | — | — | $500.0K | 5 | 2019-11-07 |
| BIOLASE, INC (BIOL) Delisted | Director | 20 | $0.02 | $0 | $0 | 9 | 2017-07-03 |
| HANSEN MEDICAL INC (HNSN) Delisted | Executive Chairman | 279,008 | — | — | $1.91M | 14 | 2012-03-05 |
Recent Filings · Page 2 of 10
94 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2024-05-31 | Shockwave Medical, Inc. (SWAV) Delisted | Disp (D) | −287,521 | $0 | EDGAR |
| 2024-02-22 | Shockwave Medical, Inc. (SWAV) Delisted | Sell (S) | −60,000 | -$15.44M | EDGAR |
| 2024-02-21 | — | Notice (144) | −60,000 | -$15.47M | EDGAR |
| 2024-02-09 | Shockwave Medical, Inc. (SWAV) Delisted | Exer (M) | +81,967 | $50.0K | EDGAR |
| 2023-12-08 | PRCT | Sell (S) | −79,000 | -$3.06M | EDGAR |
| 2023-12-06 | PRCT | Notice (144) | −79,000 | -$3.06M | EDGAR |
| 2023-06-16 | PRCT | Grant (A) | +2,711 | $0 | EDGAR |
| 2023-06-15 | Shockwave Medical, Inc. (SWAV) Delisted | Grant (A) | +736 | $0 | EDGAR |
| 2022-06-27 | Shockwave Medical, Inc. (SWAV) Delisted | Grant (A) | +994 | $0 | EDGAR |
| 2022-06-09 | PRCT | Grant (A) | +2,001 | $75.0K | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.